The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 14, 2017

Filed:

Mar. 15, 2013
Applicant:

Biogen Idec MA Inc., Cambridge, MA (US);

Inventors:

Kenneth Simon, Cambridge, MA (US);

Thomas Cameron, Cambridge, MA (US);

Mia Rushe, Everett, MA (US);

Justin Caravella, Cambridge, MA (US);

George Campbell Kaynor, Melrose, MA (US);

Assignee:

Biogen MA Inc., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/08 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/084 (2013.01); A61K 2039/505 (2013.01); C07K 2317/00 (2013.01); C07K 2317/24 (2013.01); C07K 2317/40 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

In one aspect, the disclosure provides neutralizing antibodies against JCV and methods for the treatment of PML. In some embodiments, aspects of the invention relate to an isolated JC-virus neutralizing monoclonal antibody against JCV capsid protein VPI (JCV-VP1). In some embodiments, the antibody suppresses infectivity of the JC-virus. In some embodiments, the antibody binds the sialic acid binding pocket of JCV-VPI. In some embodiments, the antibody binds JCV-VP 1 comprising one or more of the following mutations: S269F, S269Y, S267F, N265D, Q271 H, D66H, K60E, K60N and L55F.


Find Patent Forward Citations

Loading…